Johannes Bloehdorn

ORCID

Publication Activity (10 Years)

Years Active: 2021-2023
Publications (10 Years): 10

Top Venues

Blood

Nature communications

Leukemia

Science translational medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Qu Jiang, Johanna Stachelscheid, Johannes Bloehdorn, Alicja Pacholewska, Christoph Markus Aszyk, Francien Grotenhuijs, Tony Andreas Müller, Özlem Önder, Prerana Wagle, Carmen Diana Herling, Maria Kleppe, Zhefang Wang, Kevin R Coombes, Sandra Robrecht, Priya S Dalvi, Bianca Andra Lungu, Petra Mayer, Lynne V Abruzzo, Janine Altmüller, Birgit Sybille Gathof, Thorsten Persigehl, Kirsten Fischer, Billy Michael Chelliah Jebaraj, Hugh Young Rienhoff, Rupert C Ecker, Yue Zhao, Christiane Josephine Bruns, Stephan Stilgenbauer, Kojo S J Elenitoba-Johnson, Michael Hallek, Michal R Schweiger, Margarete Odenthal, Elena Vasyutina, Marco Herling
Oncogenic role and target properties of the lysine-specific demethylase KDM1A in chronic lymphocytic leukemia. Blood (2023)
Maurizio Mangolini, Alba Maiques-Diaz, Stella Charalampopoulou, Elena Gerhard-Hartmann, Johannes Bloehdorn, Andrew Moore, Giorgia Giachetti, JunYan Lu, Valar Nila Roamio Franklin, Chandra Sekkar Reddy Chilamakuri, Ilias Moutsopoulos, Andreas Rosenwald, Stephan Stilgenbauer, Thorsten Zenz, Irina Mohorianu, Clive D'Santos, Silvia Deaglio, Daniel James Hodson, José Ignacio Martin-Subero, Ingo Ringshausen
Viral transduction of primary human lymphoma B cells reveals mechanisms of NOTCH-mediated immune escape. Nature communications 13 (1) (2022)
Henriette Huber, Simone Edenhofer, Julia von Tresckow, Sandra Robrecht, Can Zhang, Eugen Tausch, Christof Schneider, Johannes Bloehdorn, Moritz Fürstenau, Peter Dreger, Matthias Ritgen, Thomas Illmer, Anna L Illert, Jan Dürig, Sebastian Böttcher, Carsten Utoft Niemann, Michael Kneba, Anna-Maria Fink, Kirsten Fischer, Hartmut Döhner, Michael Hallek, Barbara Eichhorst, Stephan Stilgenbauer
Obinutuzumab (GA-101), ibrutinib, and venetoclax (GIVe) frontline treatment for high-risk chronic lymphocytic leukemia. Blood 139 (9) (2022)
Lisa Rusyn, Sebastian Reinartz, Anastasia Nikiforov, Nelly Mikhael, Alexander Vom Stein, Viktoria Kohlhas, Johannes Bloehdorn, Stephan Stilgenbauer, Philipp Lohneis, Reinhard Buttner, Sandra Robrecht, Kirsten Fischer, Christian P Pallasch, Michael Hallek, Phuong-Hien Nguyen, Tamina Seeger-Nukpezah
The scaffold protein NEDD9 is necessary for leukemia-cell migration and disease progression in a mouse model of chronic lymphocytic leukemia. Leukemia 36 (7) (2022)
Sanne Burkert, Lynn Peters, Johannes Bloehdorn, Beate Grüner
Salvage Therapy for Alveolar Echinococcosis-A Case Series. Pathogens (Basel, Switzerland) 11 (3) (2022)
Johanna Stachelscheid, Qu Jiang, Christoph Markus Aszyk, Kathrin Warner, Nadine Bley, Tony A Müller, Olga Vydzhak, Konstantinos Symeonidis, Giuliano Crispatzu, Petra Mayer, Stuart James Blakemore, Gudrun Goehring, Sebastian Newrzela, Stephanie Hippler, Sandra Robrecht, Karl-Anton Kreuzer, Christian P Pallasch, Marcus Krueger, Axel Lechner, Kirsten Fischer, Stephan Stilgenbauer, Dirk Beutner, Michael Hallek, Daniel Auguin, Stefan Hüttelmaier, Johannes Bloehdorn, Elena Vasyutina, Marco Herling
The proto-oncogene TCL1A deregulates cell cycle and genomic stability in CLL. Blood (2022)
Heng Pan, Richard Greil, Ronan Chaligne, Johannes Bloehdorn, Eugen Tausch, Daniel Mertens, Anna Maria Fink, Kirsten Fischer, Chao Zhang, Doron Betel, Andreas Gnirke, Marcin Imielinski, Jérôme Moreaux, Michael Hallek, Alexander Meissner, Stephan Stilgenbauer, Catherine J Wu, Olivier Elemento, Dan A Landau
Discovery of Candidate DNA Methylation Cancer Driver Genes. Cancer discovery 11 (9) (2021)
Laura Beckmann, Valeska Berg, Clarissa Dickhut, Clare Sun, Olaf Merkel, Johannes Bloehdorn, Sandra Robrecht, Marc Seifert, Alexandra da Palma Guerreiro, Julia Claasen, Stefan Loroch, Matteo Oliverio, Chingiz Underbayev, Lauren Vaughn, Daniel Thomalla, Malte F Hülsemann, Eugen Tausch, Kirsten Fischer, Anna Maria Fink, Barbara Eichhorst, Albert Sickmann, Clemens M Wendtner, Stephan Stilgenbauer, Michael Hallek, Adrian Wiestner, René P Zahedi, Lukas P Frenzel
MARCKS affects cell motility and response to BTK inhibitors in CLL. Blood 138 (7) (2021)
Eugene Park, Jingyu Chen, Andrew Moore, Maurizio Mangolini, Antonella Santoro, Joseph R Boyd, Hilde Schjerven, Veronika Ecker, Maike Buchner, James C Williamson, Paul J Lehner, Luca Gasparoli, Owen Williams, Johannes Bloehdorn, Stephan Stilgenbauer, Michael Leitges, Alexander Egle, Marc Schmidt-Supprian, Seth E Frietze, Ingo Ringshausen
Stromal cell protein kinase C-β inhibition enhances chemosensitivity in B cell malignancies and overcomes drug resistance. Science translational medicine 12 (526) (2021)
Johannes Bloehdorn, Andrejs Braun, Amaro Taylor-Weiner, Billy Michael Chelliah Jebaraj, Sandra Robrecht, Julia Krzykalla, Heng Pan, Adam Giza, Gulnara Akylzhanova, Karlheinz Holzmann, Annika Scheffold, Harvey E Johnston, Ru-Fang Yeh, Tetyana Klymenko, Eugen Tausch, Barbara Eichhorst, Lars Bullinger, Kirsten Fischer, Martin Weisser, Tadeusz Robak, Christof Schneider, John G Gribben, Lekh N Dahal, Mathew J Carter, Olivier Elemento, Dan A Landau, Donna S Neuberg, Mark S Cragg, Axel Benner, Michael Hallek, Catherine J Wu, Hartmut Döhner, Stephan Stilgenbauer, Daniel Mertens
Multi-platform profiling characterizes molecular subgroups and resistance networks in chronic lymphocytic leukemia. Nature communications 12 (1) (2021)

Johannes Bloehdorn.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Johannes Bloehdorn